https://www.selleckchem.com/pr....oducts/cabotegravir-
37, 95% CI 1.01-1.93; = 0.043], snoring frequency (OR 1.37, 95% CI 1.05-1.79; = 0.02 and very loud snoring (OR 1.34, 95% CI 1.04-1.74, = 0.026). The incidence of obesity, MetS, DM, elevated fasting glucose level, triglyceridemia and sleep complaints became more frequent after a 10-year period in subjects with IR. Over a 10-year period, IR was significantly associated with an increase in sleep complaints sleep latency reflecting difficulty to fall asleep, snoring and very loud snoring. The incidence of obesity, M
Мне нравится
Комментарий
Перепост
